AstraZeneca admits its COVID vaccine, Covishield, can cause rare side effect
08-May-24 05:01:20
AstraZeneca admits Covishield's rare side effect TTS, causing blood clots with low platelets. TTS symptoms include severe headaches, abdominal pain. Treatment involves anticoagulation therapy, IVIG. "TTS is a serious and life-threatening adverse event. WHO has issued this interim emergency guidance to increase awareness about TTS in the context of COVID-19 vaccination and help healthcare providers in the assessment and management of potential TTS cases," the 2023 statement by WHO read.
A big update has emerged in connection with COVID vaccine and its rare side effects, which are being questioned by several health experts. British-Swedish multinational pharmaceutical and biotechnology company AstraZeneca has admitted in court papers that its COVID vaccine, Covishield, can cause rare side effect, The Telegraph reported.
Covishield was developed by AstraZeneca and was produced by the Serum Institute of India.
SOURCE & CREDIT: TIMES OF INDIA